Device recall: Symbiq One Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids. List number 16026. Note t

FDA enforcement event 64005 · Class II · initiated 16 Mar 2011 · status Terminated · terminated 28 Nov 2016

DeviceVoluntary: Firm initiated2 product recordsLake Forest, IL

Hospira Inc. (Lake Forest, IL) initiated this device recall on 16 Mar 2011; FDA lists 2 product records under event 64005, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 89% of the 114 device enforcement events initiated in 2011 carry the same class.

Status: Terminated, terminated 28 Nov 2016. Initiation: voluntary: firm initiated. Hospira Inc. has 151 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Hospira Inc., Lake Forest, IL.

Reason for recall

"May go to a white screen due to a problem with the SOM2 module. A white screen is a diagnostic screen displayed to the user as part of the safety shutdown procedure of the device. The infusion and the processor stop, sound a 3 minute audible alarm from the backup buzzer and deactivate the couch screen and the automated loading/unloading of cassettes. Delay or interruption of therapy."

Distribution

"Worldwide Distribution - US (nationwide) and Canada"

Product records

Recall number	Product	Quantity	Class	Status	Report date
Z-0361-2017	Symbiq One Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids. List number 16026. Note that Hospira retired this pump June 30, 2015. The Hospira Symbiq Infusion System is intended for the delivery of fluids, solutions, drugs, agents, nutritionals, electrolytes, blood, and blood…	10,337	Class II	Terminated	16 Nov 2016
Z-0362-2017	Symbiq Two Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids. List number 16027. Note that Hospira retired this pump June 30, 2015. The Hospira Symbiq Infusion System is intended for the delivery of fluids, solutions, drugs, agents, nutritionals, electrolytes, blood, and blood…	10897	Class II	Terminated	16 Nov 2016

Context

89%of 2011 device events are Class II114 events that year

2product records in this eventfirm median: 1

151events on this register for the firm

Other enforcement events for Hospira Inc.

Initiated	Product (first record)	Type	Class	Records
21 Apr 2017	Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospir	Drug	Class I	1
1 Nov 2016	Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., Lake Forest IL 6	Drug	Class II	1
15 Aug 2016	DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV Use Only, Must be Diluted Prior to Use, (12.5 mg per mL), Rx	Drug	Class II	1
29 Jun 2016	5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia	Drug	Class III	1
23 Jun 2016	Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32	Drug	Class II	1
6 May 2016	Vancomycin Hydrochloride for Injection, USP, 10 g, 100 mL vial, Rx only, Hospira, Lake Forest, IL, NDC 0409-6510-01	Drug	Class II	1
25 Mar 2016	The Plum 360 is a large volume infuser capable of delivering fluids for a variety of therapies such as parenteral, enter	Device	Class II	2
23 Mar 2016	Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial, packaged in 25 vial	Drug	Class III	1
23 Mar 2016	Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial, packaged in 25 vial	Drug	Class I	1
18 Mar 2016	8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx only, Hospira Inc, Lake Forest,	Drug	Class I	1

All 151 events for Hospira Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "May go to a white screen due to a problem with the SOM2 module. A white screen is a diagnostic screen displayed to the user as part of the safety shutdown procedure of the device. The infusion and the processor stop, sound a 3 minute audible alarm from the backup buzzer and deactivate the couch screen and the automated loading/unloading of cassettes. Delay or interruption of therapy."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - US (nationwide) and Canada"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 28 Nov 2016. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.